Related Experiment Video
Updated: Apr 17, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Prevalence and severity of depression in chronic viral hepatitis in Iran
Mojgan Mirabdolhagh Hazaveh1, Taraneh Dormohammadi Toosi2, Mohsen Nasiri Toosi3
1Rheumatology Research Centre, Vali-asr Hospital, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Insights
Chronic hepatitis C patients show higher depression rates than healthy individuals and chronic hepatitis B patients. Depression screening is recommended for managing both hepatitis B and C.
Area of Science:
- Hepatology and Gastroenterology
- Psychiatry and Mental Health
Background:
- Chronic hepatitis B (CHB) and chronic hepatitis C (CHC) are significant global health concerns.
- Mental health comorbidities, such as depression, are increasingly recognized in patients with chronic liver diseases.
- Understanding the prevalence and severity of depression in these patient groups is crucial for comprehensive care.
Purpose of the Study:
- To compare the prevalence and severity of depression among patients with CHB, CHC, and healthy controls.
- To investigate the impact of hepatitis B surface antigen (HBsAg) carrier status on depression rates in CHB patients.
Main Methods:
- A cross-sectional study involving 253 participants was conducted between 2011 and 2012.
- Depression prevalence and severity were assessed using the Hamilton Depression Rating Scale.
- Participants included CHB patients, CHC patients, and healthy individuals.
Main Results:
- The prevalence of depression was significantly higher in CHC patients (35.9%) compared to healthy participants (11.3%) and CHB patients (19.8%) (P < 0.01).
- After excluding inactive HBsAg carriers, the difference in depression prevalence between CHB and CHC patients was not significant (29.3% vs. 35.9%).
- Inactive HBsAg carriers exhibited a significantly lower depression prevalence (10.0%) compared to CHB patients excluding inactive carriers (29.3%) (P < 0.05).
- No significant differences in depression severity were observed across all groups.
Conclusions:
- Depression is more prevalent in CHC patients than in CHB patients and healthy individuals.
- The presence of inactive HBsAg carriage may be associated with lower depression rates in CHB patients.
- Routine depression screening is advisable for patients with CHB and CHC to aid in disease management.
Aim:
The aim of this study was to compare the prevalence and severity of depression in chronic hepatitis B (CHB) patients, chronic hepatitis C (CHC) patients, and healthy participants.
Methods:
Two hundred and fifty-three persons participated in this cross-sectional study between 2011 and 2012 in Imam Khomeini Hospital. The prevalence and severity of depression were assessed using the Hamilton Scale.
Results:
There was significantly higher prevalence of depression in CHC patients (35.9%) than in healthy participants (11.3%) and CHB patients (19.8%) (both P < 0.01). However, CHB and CHC patients did not differ significantly in their depression prevalence after excluding inactive hepatitis B surface antigen (HBsAg) carriers (29.3% vs. 35.9%; P > 0.05). Inactive HBsAg carriers differed significantly from CHB patients-excluding inactive HBsAg carriers-in depression prevalence (10.0% vs. 29.3%; P < 0.05). No statistically significant difference was found in depression severity between all groups (P > 0.05).
Conclusion:
Depression screening in chronic hepatitis B and chronic hepatitis C patients may be beneficial in disease management.
More Related Videos
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia
Long-term Depression

